Work

Supplementary Figure 5 from Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma

Year: 2026

Type: supplementary-materials

Abstract: Fig. S5. CAR-12.18 is efficacious and non-toxic against SB28-GKO orthotopic syngeneic glioma.

DOI: 10.1158/0008-5472.33151445

Authors: Justin D. Clubb, Ryan M. Shih, Torahito A. Gao, Amanda Shafer, Shreya Vajragiri, Katrina Lam, Sohan Talluri, Amber Bouren, Christine E. Brown, Pedro Ruivo, Robert M. Prins, Han-Chung Wu, Yvonne Y. Chen

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7172431354

Cites:

Cited by:

Related to: 10